Biomedical Engineering Reference
In-Depth Information
142. Geiser, M.; Rothen-Rutishauser, B.; Kapp, N.; Schuerch, S.; Kreyling, W.; Schulz,
H.; Semmler, M.; Hof, V.I.; Heyder, J.; Gehr, P. Ultrafine particles cross cellu-
lar membranes by nonphagocytic mechanisms in lungs and in cultured cells.
Environ. Health Perspect.
2005
,
113,
1555-1560.
143. AshaRani, P.V.; Valiyaveettil, S.; AshaRani, P.V.; Mun, G.L.K.; Hande, M.P.
Cytotoxicity and genotoxicity of silver nanoparticles in human cells.
ACS Nano
2009
,
3,
279-290.
144. Ahamed, M.; Karns, M.; Goodson, M.; Rowe, J.; Hussain, S.M.; Schlager, J.J.;
Hong, Y. DNA damage response to different surface chemistry of silver nanopar-
ticles in mammalian cells.
Toxicol. Appl. Pharmacol.
2008
,
233,
404-410.
145. Yang, H.; Liu, C.; Yang, D.; Zhang, H.; Xi, Z. Comparative study of cytotoxicity,
oxidative stress and genotoxicity induced by four typical nanomaterials: The
role of particle size, shape and composition.
J. Appl. Toxicol.
2009
,
29,
69-78.
146. Xu, A.; Chai, Y.; Nohmi, T.; Hei, T.K. Genotoxic responses to titanium dioxide nano-
particles and fullerene in gpt delta transgenic MEF cells.
Part. Fibre Toxicol.
2009
,
6,
3.
147. Raun Jacobsen, N.; Møller, P.; Alstrup Jensen, K.; Vogel, U.B.; Ladefoged, O.;
Loft, S.; Wallin, H.; Division of Toxicology and Risk Assessment, National Food
Institute, Technical University of Denmark. Lung inflammation and genotoxic-
ity following pulmonary exposure to nanoparticles in ApoE
-/-
mice.
Part. Fibre
Toxicol.
2009
,
6,
2.
148. Xia, T.; Kovochich, M.; Brant, J.; Hotze, M.; Sempf, J.; Oberley, T.; Sioutas, C.;
Yeh, J.I.; Wiesner, M.R.; Nel, A.E. Comparison of the abilities of ambient and
manufactured nanoparticles to induce cellular toxicity according to an oxida-
tive stress paradigm.
Nano Lett. (USA)
2006
,
6,
1794-1807.
149. Omidi, Y.; Hollins, A.J.; Benboubetra, M.; Drayton, R.; Benter, I.F.; Akhtar, S.
Toxicogenomics of non-viral vectors for gene therapy: A microarray study of
lipofectin- and oligofectamine-induced gene expression changes in human epi-
thelial cells.
J. Drug Target.
2003
,
11,
311-323.
150. Regnstrom, K.; Ragnarsson, E.G.E.; Fryknas, M.; Koping-Hoggard, M.; Artursson,
P. Gene expression profiles in mouse lung tissue after administration of two cat-
ionic polymers used for nonviral gene delivery.
Pharm. Res.
2006
,
23,
475-482.
151. Kreyling, W.G.; Semmler-Behnke, M.; Möller, W. Health implications of
nanoparticles.
J. Nanopart. Res.
2006
,
8,
543-562.
152. Lin, P.; Chen, J.; Chang, L.W.; Wu, J.; Redding, L.; Chang, H.; Yeh, T. et al.
Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot
705, in mice.
Environ. Sci. Technol.
2008
,
42,
6264-6270.
153. Wang, J.J.; Sanderson, B.J.S.; Wang, H. Cyto- and genotoxicity of ultrafine TiO
2
particles in cultured human lymphoblastoid cells.
Mutat. Res.
2007
,
628,
99-106.
154. Handy, R.D.; Owen, R.; Valsami-Jones, E. The ecotoxicology of nanoparticles
and nanomaterials: Current status, knowledge gaps, challenges, and future
needs.
Ecotoxicology
2008
,
17,
315-325.
155. Luoma, S.N.
Silver Nanotechnologies in the Environment: Old Problem or New
Challenge?
The Pew Charitable Trusts, Project on emerging nanotechnologies,
Washington DC,
2008
.
156. Royal Commission on Environmental Pollution.
Novel Materials in the Environment:
The Case of Nanotechnology
; Office of Public Sector Information,
2008
,
p. 146.
157. European Commission.
Towards a European Strategy for Nanotechnology
; European
Commission: Brussels, Belgium,
2004
.
